SS Innovations International, Inc. (Nasdaq: SSII) announced today that its SSi Mantra surgical robotic system has been used in more than 10,500 cumulative surgeries as of April 30, 2026. The milestone includes over 500 cardiac procedures, 170 telesurgeries, and 125 pediatric surgeries, demonstrating the system's versatility across multiple specialties.
The company reported that approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized for over 170 different types of procedures. Since its commercial launch in August 2022, the system has expanded its global installed base to more than 200 systems across eleven countries.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, highlighted the system's advanced technology and cost advantages. "Reaching 10,500 cumulative surgeries in such a short time span reflects the SSi Mantra's advanced technology, differentiated features, ease of training, user-friendliness, and clear cost advantages," he said. Dr. Srivastava also thanked healthcare institutions and surgeons for their trust in the system.
The SSi Mantra is a modular, multi-arm surgical robotic system featuring 3 to 5 modular arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and a touch panel for patient information. It also offers the optional SSi MantrAsana Tele Surgeon Console for enhanced portability and telesurgery capability. The system uses over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries.
This milestone underscores SS Innovations' mission to make robotic surgery affordable and accessible globally. The company plans to continue expanding its presence, particularly in the Indian market and beyond. For more information, visit the company's website at ssinnovations.com or its newsroom at https://tinyurl.com/ssiinewsroom.
